SUPN
Supernus Pharmaceuticals Inc
NASDAQ · Pharmaceuticals
$51.65
+2.28 (+4.62%)
Performance
1D
—
1W
+5.88%
1M
+0.56%
3M
+12.01%
6M
+21.13%
1Y
+36.17%
YTD
+4.41%
Open$50.01
Previous Close$49.37
Day High$51.99
Day Low$50.01
52W High$57.65
52W Low$29.16
Volume893.9K
Avg Volume761.2K
Market Cap2.96B
P/E Ratio—
EPS$-0.34
SectorPharmaceuticals
Volume Analysis
1.17x average volume
Technical Indicators
SMA 50
$48.85
Above
SMA 200
$42.24
Above
RSI (14)
59.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
12 analysts
Price Target
+75.9% upside
Current
$51.65
$51.65
Target
$90.83
$90.83
$64.19
$90.83 avg
$118.96
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 678.15M | 648.88M | 1.08B |
| Net Income | 75.69M | 65.18M | 226.99M |
| Profit Margin | 11.2% | 10.6% | 20.9% |
| EBITDA | 163.58M | 148.70M | 332.85M |
| Free Cash Flow | — | — | 190.42M |
| Rev Growth | +4.5% | +4.5% | +13.5% |
| Debt/Equity | — | — | 0.52 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |